Academic trials and the challenge of sponsor responsibility

Similar documents
Standard Operating Procedure (SOP) Research and Development Office

First inspection of a Legal Representative in the EU by local authority

MHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager

Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol

Suggestions for Modification of the Clinical Trials Directive ELN Annual Meeting 01 February 2011

Research Staff Training

Site Closedown Checklist for UoL Sponsored CTIMP Studies

This Agreement dated DD/MM/YYYY (the Effective Date ) is between

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

New European Union Clinical Trial Regulations

STANDARD OPERATING PROCEDURE

Safety Reporting in Clinical Research Policy Final Version 4.0

STANDARD OPERATING PROCEDURE SOP 325

Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research

Details: Approval: Distribution & Storage: Pharmacovigilance for Researchers for UoL / LTHT Sponsored CTIMPs. Standard Operating Procedure

Version Number: 003. On: September 2017 Review Date: September 2020 Distribution: Essential Reading for: Information for: Page 1 of 13

Standard Operating Procedures (SOP) Research and Development Office

Marie-Claire Rickard, RG and GCP Manager Jimena Lovos, Quality Assurance Manager Elizabeth Clough, R&D Governance Operations Manager

STANDARD OPERATING PROCEDURE

GCP INSPECTORATE GCP INSPECTIONS METRICS REPORT

1. INTRODUCTION 2. SCOPE 3. PROCESS

Standard Operating Procedure

Governance %%.4- r2&% Queen s University Belfast. Standard Operating Procedure Research Governance. r2.aoc7. Research and Enterprise

Sponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law

Standard Operating Procedure (SOP) Research and Development Office

STANDARD OPERATING PROCEDURE

STANDARD OPERATING PROCEDURE SOP 205

M. Rickard, Research Governance and GCP Manager R. Fay Research Governance and GCP Manager Elizabeth Clough, Governance Operations Manager

Informed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019

Document Title: Investigator Site File. Document Number: 019

Keele Clinical Trials Unit

Quality Assurance in Clinical Research at RM/ICR. GCP Compliance Team, Clinical R&D

Trial Management: Trial Master Files and Investigator Site Files

Overview of the IMB s. Good Clinical Practice. Deirdre O Regan GCP/Pharmacovigilance. GCP Seminar Dublin, 27 th January 2010.

Standard Operating Procedure (SOP)

Research Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004

R. Fay, Research Governance & GCP Manager K. Mahiouz, Clinical Trials Facilitator E. Clough, R&D Governance Operations Manager

Commission Guidelines for the implementation of the Clinical Trials Regulation NTA Ethics Oslo

European Medicines Agency Inspections ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS

SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup

TRAINING NEEDS FOR CPP MEMBERS IN FRANCE

Pharmacists' involvement in clinical trials and ethical committees

MANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS

Research Adverse Event and Safety Reporting Procedures Outcome Statement: Title:

CLIC Clinical Investigator (And Site Staff) Certification

Version Number: 004 Controlled Document Sponsor: Controlled Document Lead:

STANDARD OPERATING PROCEDURE

Research & Development Quality Manual

Conducting Academic Trials Under EU Law The EBMT Experience. Zoë Doran Director, Clinical Trials Operations EBMT

M Rickard, Research Governance and GCP Manager Elizabeth Clough, R&D Governance Operations Manager Rachel Fay, Research Governance and GCP Manager

Guideline for Applicants. Intramural Research Funding Programs Faculty of Medicine Tübingen

Risk Assessment. Version Number 1.0 Effective Date: 21 st March Sponsored Research

Keele Clinical Trials Unit

Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol

Standard Operating Procedure (SOP) Research and Development Office

Reference Number: UHB 253 Version Number: 1 Date of Next Review: 22/01/2018 Previous Trust/LHB Reference Number: SR-RG-015

Standard Operating Procedure:

SOP-QA-28 V2. Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School

Standard Operating Procedure Research Governance

Auditing of Clinical Trials

STANDARD OPERATING PROCEDURE

Joint R&D Support Office SOP S-2011 UHL

Submission of a clinical trial for access to ECRIN services Notice to the Applicant

Document Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator

STANDARD OPERATING PROCEDURE

SOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY. Contact Jess Bisset, Research Operations Manager x20227

Standard Operating Procedures

20th Maritime HR & Crew Management Summit Singapore

ACTIONS/PSOP/001 Version 1.0 Page 2 of 6

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

STH Researcher. Recording of research information in patient case notes

Preparation for an MHRA GCP Inspection including Training on New and Up-dated SOPs

GCP INSPECTION CHECKLIST

August 3, 2017 Clinical Trials at UNC. UNC Symposium for Research Administrators

MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS Memorandum of understanding between MHRA, COREC and GTAC

VCU Clinical Research Quality Assurance Assessment

Guidance for the conduct of good clinical practice inspections

Document Title: Document Number:

ACCREDITATION OF PHASE I UNITS AND PROTECTION OF THE SUBJECTS PARTICIPATING IN CLINICAL TRIALS IN FRANCE

Unofficial copy not valid

Dr. R. Sathianathan. Role & Responsibilities of Principal Investigators in Clinical Trials. 18 August 2015

Clinical Trials Assistant POSITION DESCRIPTION

Adverse Event Reporting

Regulatory and ethics bodies involved in approval process. Competent Authority/-ies (CA)/ For certain types of MDs Ethics committee(s)

ETHICS COMMITTEE: ROLE, RESPONSIBILITIES AND FUNCTIONS K.R.CHANDRAMOHANAN NAIR DEPARTMENT OF ANATOMY, MEDICAL COLLEGE, THIRUVANANTHAPURAM

ABMU R&D Operational Framework

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

SOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection

STANDARD OPERATING PROCEDURE SOP 715. Principles of Clinical Research Laboratory Practice

TRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP)

Scientific and Regulatory Advice by the Federal Institute for Drugs and Medical Devices (BfArM) Guidance for Applicants (Revision 9 1 )

COMPETENCY FRAMEWORK

SOP19a & 19b: Standard Operating Procedure for (a) Safety Monitoring (especially Pharmacovigilance) & (b) Urgent Safety Measures

Investigator Site File Standard Operating Procedure (SOP)

European network of paediatric research (Enpr-EMA)

STANDARD OPERATING PROCEDURE 24. Training Records

Training components for GCP. inspectors in PMDA. Tomonori Tateishi, MD, PhD Office of Conformity Audit, PMDA

Tuesday, June 19th, 2018

Standard Operating Procedure (SOP) for Reporting Urgent Safety Measures in Clinical Research

Transcription:

Academic trials and the challenge of sponsor responsibility Jochen Dress, Dr. Andrea Grunow, Dr. Christine Georgias, Dr. Ursula Paulus Clinical Trials Center Cologne Funded by BMBF 01KN1106

2 Legal Situation 2001: DIRECTIVE 2001/20/EC The European Clinical Trials Directive 2004: The 12th amendment of the German Drug Law (AMG) National implementation of the Directive 2001/20/EC 2005: RL 2005/28/EG The European GCP-Directive

3 Relevance for Investigator Initiated Trials (IITs) Legal definition of Sponsor and Clinical Trial Legal implementation of Good Clinical Practice (GCP) German Drug Law (AMG) became binding for IITs

4 Sponsor is a natural or legal person who assumes responsibility for the commissioning, organization and financing of a clinical trial on human beings. [AMG 4 (24)]

5 Sponsor for IITs Institution (University, Hospital) Investigator (rare!)

6 Challanges for the Academic Institution Defined roles and responsibilities Controlled delegation Quality management (GCP) Know how (law, background, methodology) Resources (human and financial) Risk management

7 Structure University of Cologne University Hospital CTCC Medical Faculty

8 Cologne Sponsor Model QAU University (Rector) CTCC Coordinating Investigator (CI) Sponsor Executive institution of the sponsor Sponsor s representative

9 Delegation of sponsor duties QAU CTCC CI Third Parties Financing General organisation Data management Monitoring Proof for sponsorship Insurance As appropriate Protocol / ICF Surveillance of trial conduct Pharmacovigilance Applications / approvals

10 Proof for Sponsorship: GCP Check QAU Protocol, ICF, IMPD (SmPC), Financing, contracts Insurance Investigational medicinal product (IMP release) Involvement of other countries and trial sites Pharmacovigilance Monitoring-concept Delegation of tasks to third parties, contracts and qualification

11 Surveillance of Trial Conduct QAU Audits according to a risk-based auditprogram Control samples of monitoring reports Annual trial status reports from sponsor s representatives (CI)

12 Risk-based Auditprogramm 3-4 audits per year System- and on-site- audits Focus of Audit: Fulfillment of assumed Sponsor duties GCP-Compliance Criteria/Raster (e.g.): AMG / MPG Trial multicenter phase I Low Monitoring extent

13 Reporting Line of Quality Assurance Unit QAU University (Sponsor) CTCC (Executive institution of the sponsor) CI (Sponsor s Representative)

14 Experiences I 52 applications for University sponsorship 36 trials accepted (5 international) All with subsequent improvement 16 remaining In preparation, cancelled or postponed (financing, organisation, other reasons)

15 Experiences II: Audit Findings CI (trial conducting unit) Roles and responsibilities unclear Missing approval processes Clinical monitoring low, follow up and consequences of findings missing Trial ICF incorrect SAE not reported or delayed Delay in documentation Violation of in- and exclusion criteria...

16 Side step: Support by CTCC Know How: IIT manual Academy (basic and advanced training) QM-Coaching: establishment of quality management in the CI s facility (i.e. SOP & contract templates, audit action plan) Service Provider: Services of all aspects of a clinical trial (methodological and medical)

17 Acceptance and Financing of the Cologne Sponsor Model High acceptance by public and corporate financiers of IITs as well as authorities!! Financing: 2 FTE (1 Medical Faculty, 1 funded by Federal Ministry of Education and Research) Sustainability by project-specific take over of audit costs (planned) funded by the

18 Summary The Cologne Sponsor Model provides...... a risk-based system... with a combination of central management, control and support... and of decentral measures...that offers a sensible option for fulfilling the legal and GCP requirements for the academic environment.

19 Thank you for your attention Jochen Dress Team Leader IT, Quality Advisor, Project Manager Tel: (+49)221 47888131 Fax: (+49)221 478 88209 jochen.dress@zks-koeln.de zks-sponsor@zks-koeln.de Clinical Trial Center Cologne www.zks-koeln.de

20 Perspective / International Trials Analogous delegation model Allocation of entire sponsor duties One national organizational unit University CTCC National unit/ci Synergies with ECRIN in international Trials

21 CTCC: Clinical Trials Center Cologne Managing Board Quality Assurance (QAU) Methodological Division Medical Division

22 CTCC Services Methodological Division Project Management Data Management SAE / SUSAR Management Medical Division Translational research Site Management IT Medicine Monitoring IT Quality Management (i.e. coaching) Training Academy